Meritage Portfolio Management’s Gilead Sciences GILD Stock Holding History

Meritage Portfolio Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.12M	Sell	49,853 -242	-0.5%	-$29.4K	0.41%	64
2025 Q3	$5.56M	Sell	50,095 -824	-2%	-$93.7K	0.37%	74
2025 Q2	$5.65M	Sell	50,919 -1,361	-3%	-$145K	0.36%	75
2025 Q1	$5.86M	Sell	52,280 -2,596	-5%	-$268K	0.39%	70
2024 Q4	$5.07M	Sell	54,876 -3,727	-6%	-$336K	0.31%	83
2024 Q3	$4.91M	Sell	58,603 -2,447	-4%	-$187K	0.3%	105
2024 Q2	$4.19M	Sell	61,050 -1,155	-2%	-$77.1K	0.26%	116
2024 Q1	$4.56M	Sell	62,205 -3,353	-5%	-$258K	0.29%	114
2023 Q4	$5.31M	Sell	65,558 -342	-0.5%	-$26.6K	0.35%	85
2023 Q3	$4.94M	Sell	65,900 -902	-1%	-$69.4K	0.36%	92
2023 Q2	$5.15M	Buy	66,802 +2,344	+4%	+$187K	0.36%	95
2023 Q1	$5.35M	Buy	64,458 +1,561	+2%	+$129K	0.4%	84
2022 Q4	$5.4M	Buy	62,897 +2,029	+3%	+$161K	0.42%	79
2022 Q3	$3.75M	Buy	60,868 +2,711	+5%	+$171K	0.31%	97
2022 Q2	$3.6M	Buy	58,157 +902	+2%	+$55.8K	0.28%	116
2022 Q1	$3.4M	Buy	57,255 +14,691	+35%	+$939K	0.21%	128
2021 Q4	$3.09M	Sell	42,564 -3,025	-7%	-$208K	0.18%	131
2021 Q3	$3.18M	Sell	45,589 -128	-0.3%	-$8.99K	0.19%	128
2021 Q2	$3.15M	Buy	45,717 +203	+0.4%	+$13.6K	0.19%	142
2021 Q1	$2.94M	Buy	45,514 +38,066	+511%	+$2.45M	0.2%	144
2020 Q4	$434K	Hold	7,448	–	–	0.03%	214
2020 Q3	$471K	Sell	7,448 -84	-1%	-$5.83K	0.04%	192
2020 Q2	$580K	Sell	7,532 -51,610	-87%	-$3.96M	0.06%	173
2020 Q1	$4.42M	Sell	59,142 -322	-0.5%	-$22.3K	0.6%	46
2019 Q4	$3.86M	Buy	59,464 +51,696	+665%	+$3.37M	0.34%	94
2019 Q3	$492K	Buy	7,768 +320	+4%	+$20.9K	0.05%	190
2019 Q2	$503K	Hold	7,448	–	–	0.05%	197
2019 Q1	$484K	Sell	7,448 -25	-0.3%	-$1.66K	0.05%	162
2018 Q4	$467K	Buy	7,473 +25	+0.3%	+$1.75K	0.05%	158
2018 Q3	$575K	Hold	7,448	–	–	0.05%	171
2018 Q2	$527K	Hold	7,448	–	–	0.05%	181
2018 Q1	$562K	Hold	7,448	–	–	0.05%	177
2017 Q4	$533K	Sell	7,448 -3,725	-33%	-$283K	0.05%	172
2017 Q3	$906K	Hold	11,173	–	–	0.09%	161
2017 Q2	$791K	Hold	11,173	–	–	0.08%	165
2017 Q1	$759K	Sell	11,173 -350	-3%	-$24.6K	0.08%	158
2016 Q4	$825K	Sell	11,523 -105,729	-90%	-$7.86M	0.09%	153
2016 Q3	$9.28M	Sell	117,252 -349	-0.3%	-$28.4K	1.02%	18
2016 Q2	$9.81M	Sell	117,601 -1,560	-1%	-$138K	1.1%	15
2016 Q1	$10.9M	Sell	119,161 -895	-0.7%	-$80.7K	1.24%	15
2015 Q4	$12.1M	Buy	120,056 +33,115	+38%	+$3.45M	1.37%	5
2015 Q3	$8.54M	Buy	86,941 +34,304	+65%	+$3.81M	0.99%	16
2015 Q2	$6.16M	Sell	52,637 -7,267	-12%	-$794K	0.65%	46
2015 Q1	$5.88M	Buy	59,904 +25,036	+72%	+$2.54M	0.59%	61
2014 Q4	$3.29M	Sell	34,868 -817	-2%	-$84.5K	0.35%	155
2014 Q3	$3.8M	Buy	35,685 +29,815	+508%	+$2.92M	0.43%	134
2014 Q2	$487K	Hold	5,870	–	–	0.05%	183
2014 Q1	$416K	Hold	5,870	–	–	0.05%	181
2013 Q4	$441K	Hold	5,870	–	–	0.05%	180
2013 Q3	$369K	Sell	5,870 -1,500	-20%	-$89.6K	0.05%	185
2013 Q2	$378K	Buy	+7,370	New	+$384K	0.05%	182

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Meritage Portfolio Management's GILD Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Gilead Sciences (GILD) stake by 0.48% in Q4 2025, selling an estimated $29.4K and leaving 49,853 shares worth $6.12M. The position accounts for 0.41% of the portfolio, ranked #64.

Meritage Portfolio Management first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.1M in Q4 2015. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Meritage Portfolio Management held 49,853 shares of Gilead Sciences worth $6.12M as of Q4 2025.
Meritage Portfolio Management sold 242 Gilead Sciences shares in Q4 2025, an estimated $29.4K.
Gilead Sciences made up 0.41% of Meritage Portfolio Management's portfolio in Q4 2025, its #64 holding.
Meritage Portfolio Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
Meritage Portfolio Management's Gilead Sciences position peaked at $12.1M in Q4 2015.
2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.